https://www.********.au/2019/09/24/i-would-buy-and-hold-cochlear-and-these-asx-healthcare-shares/replace ****with f o o l
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%